Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (9,960,595)	$ (2,064,910)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	4,248,199	455,670
Amortization of debt issuance costs	789,725	9,294
Interest payment added to debt principal		129,244
Stock based compensation expense related to issuance of restricted stock	17,754
Unrealized foreign currency adjustment	1,278,049	135,618
Changes in operating assets and liabilities:
Other assets, net	(468,569)	(32,369)
Accounts payable and accrued liabilities	1,294,917	305,996
Due to affiliates	145,899	(9,479)
Net cash used in operating activities	(2,654,621)	(1,070,936)
Cash flows from investing activities:
Purchase of real estate facilities	(160,100,702)	(21,555,014)
Additions to real estate facilities	(779,785)	(121,335)
Deposits on acquisitions of real estate facilities	(240,141)	(432,019)
Investments in unconsolidated real estate ventures	(378,714)	(208,343)
Net cash used in investing activities	(161,499,342)	(22,316,711)
Cash flows from financing activities:
Proceeds from issuance of secured debt	118,844,752	4,800,000
Repayment of secured debt	(30,608,851)
Prepaid debt issuance costs	(250,000)	(40,265)
Debt issuance costs	(1,325,011)	(119,836)
Gross proceeds from issuance of common stock	89,704,540	31,884,317
Proceeds from issuance of noncontrolling interest in our Operating Partnership		7,000
Offering costs	(7,986,801)	(4,395,176)
Distributions paid to common stockholders	(2,372,829)	(170,125)
Distributions paid to noncontrolling interest in our Operating Partnership	(229,594)	(115,266)
Net cash provided by financing activities	165,776,206	31,850,649
Impact of foreign exchange rate changes on cash and restricted cash	(807,829)
Net change in cash, cash equivalents and restricted cash	814,414	8,463,002
Cash, cash equivalents and restricted cash, beginning of year	4,580,759
Cash, cash equivalents and restricted cash, end of period	5,395,173	8,463,002
Supplemental disclosures and non-cash transactions:
Cash paid for interest	1,926,716
Deposits applied to purchase of real estate		200,000
Real estate assumed in consolidation of Operating Partnership		16,284,439
Investment in unconsolidated real estate venture assumed in consolidation of Operating Partnership		3,711,918
Debt assumed in consolidation of Operating Partnership		14,237,599
Non controlling interest assumed in connection with consolidation of Operating Partnership		4,574,294
Distribution payable to noncontrolling interest in our Operating Partnership assumed in consolidation of Operating Partnership		22,594
Accounts payable, accrued liabilities and due to affiliate assumed in consolidation of Operating Partnership		1,318,303
Other assets assumed in consolidation of Operating Partnership		153,146
Proceeds from issuance of common stock in accounts payable and accrued liabilities	(478,400)	(50,000)
Offering costs included in accounts payable and accrued liabilities	891,748	279,814
Interest rate swap contract in AP and Accrued Expenses	19,085
Foreign currency translation adjustment	295,568
Issuance of shares pursuant to distribution reinvestment plan	1,661,899	142,446
Distributions payable to common stockholders	676,811	130,660
Distributions payable to noncontrolling interests in our Operating Partnership	$ 27,134	22,616
Other assets in due to affiliates		371,600
Offering costs in due to affiliates		$ 47,885